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Renal iron handling in the nephrotic syndrome
ALLEN C. ALFREY and WILLIAM S. HAMMOND
Department of Medicine and Pathology, Renal Division, Veterans' Administration Medical Center, Denver, Colorado, USA
Renal iron handling in the nephrotic syndrome. Renal iron handling
was characterized in three experimental models of the nephrotic
syndrome: puromycin aminonucleoside, adriamycin and nephrotoxic
serum. In adriamycin-induced nephrotic syndrome, which has previ-
ously been shown to result from alterations in pore size of the filtration
barrier, the transferrin leak was most severe with a fractional clearance
of 25%, a value identical to albumin. In contrast, in puromycin
nephrotic syndrome and nephrotoxic serum nephritis the fractional
clearance of transferrin was never greater than 2% and consistently less
than the fractional clearance of albumin. The fact that iron/transferrin
ratios in urine and serum were frequently different, sometimes higher
other times lower, documents that iron and transferrin can be dissoci-
ated in tubule fluid and handled differently in regards to tubule uptake.
Kidney iron concentration is also increased in both immunological and
non-immunological forms of nephrotic syndrome. In the proximal
tubule iron is present largely on the luminal aspect of the cell. In
contrast, the major deposition of iron occurs in the lysosomes of the
distal tubule cells. Kidney iron concentration does not correlate with
tubule fluid iron content but can be prevented from increasing by
systemic iron and/or transferrin depletion. This suggests that iron enters
the distal tubule cells with transferrin via its receptors from the
basolateral side of the distal tubule cells. In association with the
increase tubule fluid and kidney iron, there is a marked reduction in
kidney selenium and copper content. It is concluded that urinary iron
and transferrin losses can vary greatly in different types of experimental
renal diseases, and that iron and transferrin can be dissociated in the
tubule fluid. The increase iron in association with the reduction of
copper and selenium, presumably with their respective enzymes, could
place the kidney at risk for injury from free radicals.
Previously there has been little interest in characterizing the
renal handling of iron in the nephrotic syndrome. Because of
this there have been no experimental studies and only a few
clinical studies directed at characterizing the renal handling of
iron [1—6]. However, recently it has been suggested that the
increased tubule fluid iron present in the nephrotic syndrome,
as a result of the glomerular transferrin leak, may be responsi-
ble for the tubulo-interstitial disease resulting from glomerular
disease [7]. Since iron is delivered to the tubule fluid with
transferrin, it seems possible that the type of glomerular disease
might be important in determining the amount of transferrin
presented to the tubule fluid. This in turn would suggest that the
amount of tubule fluid iron could also vary widely between
different types of glomerular diseases. Although transferrin's
molecular weight of 77,000 is not very different from albumin
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and it has been used for a marker of the renal handling of
albumin [8], there are some major differences between these
two proteins. In contrast to albumin, which is a spherical
protein having a molecular radius of 36 angstroms, transferrin is
globular in configuration with its molecular axes being 28 by 55
angstroms [9]. In addition it has less of a negative charge than
albumin. This would suggest that its glomerular leak would be
effected much more by alteration in pore size than charge.
Besides the increased tubule fluid iron found in the nephrotic
syndrome recent studies have found that renal parenchymal
iron is also increased, at least in some proteinuric states [7]. The
reason for the increased kidney iron content is unknown in that
it has been found not to correlate with the iron level in tubule
fluid [7].
This study was undertaken to characterize renal iron metab-
olism in experimental models of the nephrotic syndrome in rats.
Two of the models, adriamycin and puromycin aminonucleo-
side, were selected because the protein leak in the former has
been shown to result from alteration in pore size; in the latter
the leak results from alteration in charge [10, lii.
Methods
Uninephrectomized male Sprague-Dawley rats were used in
all experimental models of the nephrotic syndrome. Puromycin
nephrotic syndrome was induced by the administration of either
33 mg of puromycin aminonucleoside intraperitoneal (6 rats) or
5 mg/100 grams body weight i.v. (10 rats). Adriamycin ne-
phrotic syndrome was induced by administering 7.5 mg/kg body
wt of this compound intravenously through the tail vein to eight
rats. Nephrotoxic serum nephritis (NSN) was produced in 38
rats by previously described techniques employing rabbit anti-
rat glomerular basement membrane serum [12]. In 20 of these
rats urine and blood were obtained at 48 days and then killed 59
days following injection of nephrotoxic serum. Six rats with
NSN were killed 30 days and the remaining 12 150 days after
receiving a less potent nephrotoxic serum for the measurement
of kidney copper, iron and selenium levels. Six animals in this
latter group were thyroparathyroidectomized (TPTX) prior to
receiving nephrotoxic serum [131. Iron deficiency was induced
in one group of animals with nephrotoxic serum nephritis by
periodic blood drawing prior to the induction of NSN and
maintaining the animals throughout the study period on a low
iron diet (AIN-76, ICN, Costa Mesa, California, USA) [7]. The
puromycin and adriamycin groups were studied serially over a
42 day period. For urine collections all the animals were placed
on a low iron rat chow while in Nalgene metabolic cages to
reduce contamination of urine with dietary iron.
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Table 1. Experimental glomerulonephritis
NSN Puromycin Adriamycin
Plasma Cr mg/dl
Total urine protein
mg/24 hr
Serum albumin
mg/dl
FE albumin %
FE transferrin %
0.97 0.19
479 206
1320 400
1.68 0.32
1.14 0.25
0.84 0.19
558 204
1110 250
1.98 0.87
0.62 0.51
0.90 0.18
556 124
370 78
24 ioa25 l1
Urinary and serum albumin and transferrin were measured by
a nephelometric method employing antibodies obtained from
Organon Teknika Inc. (Malvern, Pennsylvania, USA).
Serum, urinary and kidney iron determinations were per-
formed with a flamless atomic absorption technique utilizing a
model 5000 Perkin-Elmer atomic absorption spectrophotometer
equipped with an automatic sampler and Zeeman background
correction. Urine and serum creatinine were measured with a
Beckman creatinine analyzer. Selenium and copper were mea-
sured with an X-ray fluorescence method [141.
For statistical analyses comparison of multiple groups was
evaluated by analysis of variance and intragroup comparisons
with a paired t-test. All values are given as mean 1 SD.
Results
The plasma creatinine, urine protein excretion, serum albu-
min and fractional excretion of albumin and transferrin for the
three models of glomerulonephritis are given in Table 1. Plasma
creatinine was similar in the three models. In the puromycin
and nephrotoxic serum nephritis models fractional excretion of
albumin was less than 2% and fractional excretion of transferrin
was consistently less than albumin. In contrast, in adriamycin-
induced nephrotic syndrome the fractional excretion of trans-
ferrin and albumin were equal and greater than 20%. This large
protein leak was further manifested by a marked reduction in
serum albumin levels (normal 3213 305 mgldl) in the adriamy-
cm group (Table 1). Urinary protein and albumin excretion was
similar in all three groups of animals. Since urinary albumin
excretion reflects the rate of albumin production, this suggests
that the maximum production rate of albumin had been reached
in all groups of animals. Thus the marked difference in plasma
albumin levels resulted from the variation in albumin clearance.
The changes in serum and urine transferrin and iron during
the course of puromycin induced nephrotic syndrome are
shown in Figures 1 and 2. There was a rapid fall in serum iron
and transferrin levels following the administration of puromy-
cm. As the nephrotic syndrome abated the levels of transferrin
and iron returned toward control values. During the early phase
of the study urinary iron:transferrin ratio was approximately
half the ratio found in blood (0.28 0.07 vs. 0.47 0.19 g
iron/mg transferrin, P < 0.05). In contrast, later in the study
during the recovery phase, the iron:transferrin ratio was re-
versed, being up to 7 times greater in the urine than the blood
(Fig. 2). Similarly in the autologous phase of nephrotoxic serum
nephritis the urinary iron transferrin ratio was greater in urine
than blood (0.97 0.12 vs. 0.64 .07 iron/mg transferrin, P
<0.01).
The changes in serum and urine transferrin and iron during
the course of adriamycin-induced nephrotic syndrome are
shown in Figures 3 and 4. Serum iron and transferrin rapidly
decreased with the induction of the nephrotic syndrome and
these changes persisted throughout the study period. This was
associated with a continuing urinary loss of iron and transferrin.
However, unlike puromycin and nephrotoxic serum nephritis
nephrotic syndromes, the iron transferrin losses were relatively
constant throughout the study period with the ratio being
similar to that found in serum.
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Fig. 2. Urinary iron (solid bars) and transferrin (open bars) during the
course of puromycin-induced nephrotic syndrome.
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Abbreviation is: FE, fractional excretion.
a P < 0.01 between groups.
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Fig. 1. Serum iron (solid bars) and transferrin (open bars) in animals
with nephrotic syndrome induced by puromycin aminonucleoside.
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Fig. 3. Serum iron (solid bars) and transferrin (open bars) during the
course of adriamycin-induced nephrotic syndrome.
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The kidney iron concentrations found in the various groups
are shown in Figure 5. Kidney iron concentration was markedly
increased in the nephrotoxic serum nephritis and puromycin
groups (P < 0.01). It was slightly increased above normal in the
adriamycin group (P < 0.05), but this increase in iron was
significantly less than that found in the NSN and puromycin
groups (P < 0.01). In the iron deficient group of animals with
NSN kidney, iron was significantly decreased from controls and
did not change with induction of NSN. Using prussian blue
stain iron was found to be most densely deposited in the distal
tubules (Fig. 6) in NSN and puromycin induced nephrosis. In
these tubules it was present largely in lysosomes and rarely in
the mitochondria (Fig. 7 and 8). In contrast in the proximal
tubule iron was present in the cytoplasm and along the brush
border (Fig. 6).
In association with the increase kidney concentration of iron
there was also a marked decrease in kidney selenium and
copper, as shown in an additional group of animals with
nephrotoxic serum nephritis which were killed 30 days and 150
days after receiving nephrotoxic serum (Table 2). It can be
further appreciated that kidney iron increased and selenium and
copper decreased relatively early during the course of NSN.
Thyroparathyroidectomy, a maneuver previously shown to be
protective of renal functional deterioration and to reduce pro-
teinuria in NSN also prevented iron accumulation and renal
selenium and copper depletion (Table 2). This supports a
relationship between the alteration of these three elements and
histological injury.
Discussion
These studies document that the renal handling of transferrin
can be different in nephrotic syndromes of varying etiologies. In
the nephrotic syndrome induced by the aminonucleoside of
puromycin, where the defect is felt to result from loss of charge
on the glomerular filtration barrier, the fractional excretion of
albumin far exceeds that of transferrin [101. The findings were
similar in the autologous phase of nephrotoxic serum nephritis,
a model of membranous nephropathy [7]. In adriamycin in-
duced nephropathy the fractional excretion of albumin and
transferrin are identical and much greater than the former two
types of experimental renal disease. This later type of nephrotic
syndrome has been shown to result from an alteration in pore
size of the glomerular filtration barrier [11]. These studies also
document that transferrin and iron are dissociated in the urine,
at least in puromycin induced and NSN nephrotic syndromes.
Early during the course of the nephrotic syndrome induced by
puromycin, the iron:transferrin ratio in urine is only about 50%
of that found in blood. However, later in the course of this
disease this ratio in urine increases to up to seven times that
found in blood. In fact, during this period the ratio was
frequently greater than 1.4 sg iron/mg transferrin. This docu-
ments that iron was far in excess of the amount that could be
bound by the amount of transferrin present in the urine. This
suggests that early in the course of this disease iron is taken up
by the tubule cells without transferrin. Later, this iron is
released into the tubule fluid probably in association with
cellular debris, as suggested by the histological findings in the
proximal tubule cells. The most obvious reason for the disso-
ciation of iron and transferrin in the tubule fluid is the reduced
pH and bicarbonate content of the tubule fluid as compared to
blood [15]. In contrast to NSN and puromycin induced disease,
in adriamycin nephrotic syndrome urine and blood iron:trans-
ferrin ratios were identical, at least in the stage of the disease
studied. It would seem that, unlike the former states, either iron
and transferrin are taken up together by the tubules or that
neither is taken up by the tubules. In view of the fact that the
urine/blood ratio of transferrin and albumin were identical, this
would imply that either fractional uptake of these two proteins
was the same or more, likely, that neither were removed from
tubule fluid. This could suggest that either adriamycin damages
the proximal tubule cells or, because of the magnitude of the
protein leak, that the capability for cellular uptake is saturated.
These studies also show that serum iron can be reduced in the
nephrotic syndrome either as a result of iron deficiency or
urinary loss of transferrin. It would appear in puromycin-
induced nephrotic syndrome that the early fall in transferrin is
a consequence of both the magnitude of protein loss and the
inability to acutely increase transferrin production. In contrast,
with adriamycin there is a continuing large urinary loss of
transferrin throughout the period of study.
It is further shown in immunologically as well as non-
immunologically induced experimental nephrotic syndrome
that kidney iron concentration can be markedly increased. It
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Fig. 4. Urinary iron (solid bars) and transferrin (open bars) losses
throughout the course of adriamycin-induced nephrotic syndrome.
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Fig. 5. Kidney iron concentration in animals with NSN (nephrotoxic
serum nephritis), NSN low (nephrotoxic serum nephritis, low iron), Ad
(adriamycin), PAN (puromycin aminonucleoside) and C (control).
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Fig. 6. Heavy accumulation offerric iron in the cells of a distal tubule (D). Smaller amounts of iron are present in the cytoplasm of some of the
proximal tubular cells (P) and focally along the brush borders (arrow). Prussian blue stain, x256.
Fig. 7. Dense aggregates of iron in lysosomes in distal tubular cells (x1I,500).
Table 2. Kidney elemental alterations
NSN 150d
Controls NSN 30d NSN 150d (TPTX)
Plasma Cr mg/dl 0.65 0.2 0.98 O.2' 2.33 l.2 0.7 0.2"
Urine protein 10 5 255 75 497 l37 134
mg/24 hr
Iron mg/kg 181 36 260 79 488 229 159 39"
Selenium mg/kg 8.6 0.7 5.6 l.5 3.8 0.8k 7.9 11b
Copper mg/kg 37 8 14 4 12 3 25 7a.b
Abbreviation is: TPTX, thyroparathyroidectomy.
a P < 0.01 between controls.
b P < 0.01 between NSN 150d.
Fig. 8. Rarely, iron is demonstrated in mitochondria (arrow) as well as
in lysosomes in distal tubular cells (x50,750).
was also found by using prussian blue staining that the largest
accumulation of iron occurred in the distal tubule cell, Electron
micrographs further demonstrated that iron deposits in the
distal nephron were largely present in lysosomes and rarely in
the mitochondria. Iron was found to be present in the proximal
tubule, but in much less concentration than was found in the
distal tubule. Its location also was different, being present
mainly in the cytoplasm and at the brush border. In contrast to
puromycin and nephrotoxic serum nephritis, kidney iron was
only modestly increased in the kidneys obtained from animals
with adriamycin induced nephropathy.
It would appear unlikely that the increased tubule fluid iron is
responsible for most of the increased kidney iron content. It has
previously been shown in iron deficient animals with nephro-
toxic serum nephritis that urine and kidney iron levels can be
dissociated [7]. This is further suggested in the adriamycin
group of animals, where urine iron was higher and the duration
of iron leak more protracted than the other groups, and yet
kidney iron was significantly less. Another factor which makes
tubule fluid iron an unlikely cause for most of the increased
kidney iron is that the majority of the excess iron is deposited in
the distal tubule cells. It has been well documented that
endocytosis of tubule fluid protein is largely restricted to the
proximal tubule, which makes it unlikely that iron was taken up
in association with transferrin by the distal tubule cells [16].
Since there are transferrin receptors on the basolateral aspect of
the distal tubule cells [17], it seems more likely that the excess
iron resulted from transferrin transporting iron intracellularly
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via its receptors. The two factors associated with a reduction of
kidney iron concentration in the nephrotic syndrome are de-
creased serum iron levels, as found in iron deficiency [7] and
low transferrin levels in association with low iron levels, as
found in adriamycin induced nephropathy. Both of these factors
would limit the availability of iron to be transported intracellu-
larly. It is unclear at this time why distal tubule iron is increased
in the nephrotic syndrome. However, it is possible that this
represents a defence system in a diseased kidney, much as that
which occurs with infection, where the organism attempts to
immobilize iron [18].
It is of additional interest that in association with the in-
creased kidney iron content, there is a marked reduction in
kidney selenium and copper levels. In support of the fact that
these three elemental alterations are related is that thyropara-
thyroidectomy, in association with prevention of renal damage
in NSN, also prevents renal iron accumulation and copper and
selenium depletion. These latter two elements are essential for
glutathione peroxidase [191 and supraoxide dismutase activity
[201. Since iron is able to catalyze the Haber-Weiss reaction,
the increase in renal and tubule fluid iron in association with a
reduction in these elements and their respective enzymes, could
markedly predispose the kidney to injury from hydroxyl radi-
cals [21]. This is supported by the fact that tissue concentration
of selenium has been shown to correlate closely with glutathi-
one peroxidase activity [19, 22, 231.
In summary, these studies document that the renal handling
of transferrin and albumin can vary markedly in different types
of experimental glomerular diseases. They further show that
iron and transferrin can be dissociated in urine. Although the
present studies would be consistent with recent studies suggest-
ing that tubular fluid iron may be important in the pathogenesis
of the tubulo-interstitial disease which accompanies glomerular
diseases [7], additional studies are required to confirm and
extend these observations.
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